Publications

Anatomical Pathology

Biochemistry

Genetics and Molecular Pathology

Haematology

Microbiology

An

ato

mic

al P

ath

olo

gy

Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar Beena, Wainer Z, Brown

T, Schneider-Kolsky M, Conron M, Wright G, Watkins DN. The prognostic significance of

aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small

cell lung cancer. Thorax. 2013 Aug 7

Muhammad Alamgeer, Vinod Ganju, Beena Kumar, Jane Fox, Stewart Hart, Michelle White,

Marion Harris, John Stuckey, Zdenka Prodanovic, Michal E Schneider and D Neil Watkins.

Changes in ALDEHYDE DEHYDROGENASE-1 (ALDH1) expression during neoadjuvant

chemotherapy predict outcome in locally advanced breast cancer. Breast Cancer Research.

Breast Cancer Res. 2014; 16(2): R44

- Chian A. Chang, Beena Kumar, and Deepali Nandurkar. A Case Report of High 18F-FDG

PET/CT Uptake in Progressive Transformation of the Germinal Centers. Medicine. CLINICAL

CASE REPORT Medicine 94(23):e412).

- Naseem Mirbagheri · Beena Kumar · Siddhartha Deb · Benjamin R Poh · Jonathan G Dark ·

Christopher C Leow William M K Teoh. Lymph node status as a prognostic indicator after

preoperative neoadjuvant chemoradiotherapy of rectal cancer. Colorectal Disease

06/2014; 16(10). DOI:10.1111/codi.12682

Treatment of chronic antibody mediated rejection with a protocol including a single fixed

low-dose of Ritxumab. PI: Dr W Mulley.

Signalling pathways in antibody mediated renal allograft rejection. PI: Dr William Mulley.

Evaluation of oncogenic signalling pathways in resected glioblastoma samples at initial

diagnosis and recurrence. PI: Dr J Lickliter.

The correlation between pre-operative evaluation of regional neck disease with Positive

Emission Topography and histopathological specimens in head and neck squamous cell

carcinoma. PI: Ms E Sigston.

Bio

che

mis

try Lu ZX, Walker KZ, O’Dea K, Sikaris KA & Shaw JE. HbA1c for screening and diagnosis of Type 2

diabetes in routine clinical practice. Diabetes Care 2010; 33:817–819

Gagnon C. Lu ZX. Magliano DJ. Dunstan DW. Shaw JE. Zimmet PZ. Sikaris K. Grantham N. Ebeling

PR. Daly RM. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5

years: results from a national, population-based prospective study (the Australian Diabetes,

Obesity and Lifestyle study). Diabetes Care. 2011; 34(5):1133-8.

Huynh J, Lu T, Liew D, Doery JCG, Tudball R, Jona M, Bhamshee R, Rodda C The VINE study. An

RCT comparing daily and bolus supplementation in breastfed infants of vitamin D deficient

mothers Submitted (NEJM June 2015) Lancet August 2015

Lee MKV, Vasikaran S, Doery JCG, Wijeratne N, , Prentice D. Cortisol:ACTH ratio for screening for

primary hypoadrenalism: A pilot study Postgrad Med J 2013;89:617-620

Fedele PL, Choy KW, Doery JCG, Grigoriadis G, Shortt J, Lu ZX Inter-laboratory discordance of

beta-2 microglobulin results: impact on the validity of the international staging system for

multiple myeloma Brit J Haemat2014;166:951-953

The Role of Adrenal Vein Sampling in Primary Aldosteronism: the Monash Health Experience Int

Med J Accepted August 2015

Yen T, Cowley D, Doery JCG, Haworth E, Lewis B, McKay R, Metz M, Mottram B, Coakley J The

AACB workshop on harmonised reference limits – Recommendations for pediatric reference

intervals Clin Biochem Rev 2012; 33; Suppl S39

Teng J, Hutchinson ME, Chee NYN, Doery JCG, Choy KW, Chong W, Fuller PJ, Yang J Effect of

adrenocorticotropic hormone stimulation on the outcomes of adrenal vein sampling in primary

aldosteronism Endocrine Society of Australia ASM 2015

Ge

ne

tics

an

d M

ole

cula

r P

ath

olo

gy Eggermann T, Brioude F, Russo S, Lombardi M, Bliek J, Maher E, Larizza L, Prawitt D, Netchine I,

Gonzales M, Gronskov K, Tümer Z, Monk D, Mannens M, Chrzanowska K, Krajewska-Walasek M,

Begemann M, Soellner L Eggermann K, Nevado J, Moore G, Mackay D, Temple K, Gillessen-

Kaesbach G, Ogata T, Weksberg R, Algar E, and Lapunzina P. 2015.Prenatal molecular testing for

Beckwith-Wiedemann and Silver-Russell syndromes: A challenge for molecular analysis and

genetic counseling Paper #544-15-EJHGR. In press.

Heath J, Smibert E, Algar E.M, Dite G.S, Hopper J. (2014). Cancer risk for relatives of children with

cancer. J Cancer Epidemiol. 2014:806076. doi: 10.1155/2014/806076. Epub 2014 Mar 27.

Eggermann T, Algar E, Lapunzina P, Mackay D, Maher ER, Mannens M, Netchine I, Prawitt D, Riccio

A, Temple IK, Weksberg R. 2013 Clinical utility gene card for: Beckwith-Wiedemann syndrome.

Eur J. Hum Genet. doi: 10.1038/ejhg.2013.132. Epub 2013 Jul 3.

Bandopadhayay P, Jabbour AM, Riffkin C, Salmanidis M, Gordon L, Popovski D, Rigby L, Ashley DM,

Watkins DN, Thomas DM, Algar E, Ekert PG.(2013). The oncogenic properties of EWS/WT1 of

desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic

fibroblasts. BMC Cancer. Dec 9;13:585. doi: 10.1186/1471-2407-13-585.

Birks DK, Donson AM, Patel PR, Sufit A, Algar EM, Dunham C, Kleinschmidt-Demasters BK, Handler

MH, Vibhakar R, Foreman NK. 2013. Pediatric rhabdoid tumors of kidney and brain show many

differences in gene expression but share dysregulation of cell cycle and epigenetic effector

genes. Pediatr Blood Cancer. Feb 4. doi: 10.1002/pbc.24481.

Hu M, Fletcher J, McCahon E, Catchpoole D, Zhang GY, Wang YM, Algar EM, Alexander SI. Bilateral

Wilms Tumor and Early Presentation in Pediatric Patients Is Associated with the Truncation of

the Wilms Tumor 1 Protein J Pediatr. 2013. Feb 9. doi:pii: S0022-3476(12)01569-7.

10.1016/j.jpeds.2012.12.080.

Daniel E. Sabbath, Elizabeth M. Algar,, Pritish K. Bhattacharyya, Karen E. Bijwaard, Tao Hong, Neal

Lindeman, Rajyalakshmi Luthra Richard D. Press, Paul G. Rothberg, Rana Domiati Saad, Zeba N.

Singh, Emily S. Winn-Deen. 2012. Nucleic Acid Amplification Assays for Molecular

Hematopathology; Approved Guideline Second Edition MM05-A2 CLSI Vol 32, No 6.

Lin Rigby, Andrea Muscat, David Ashley and Elizabeth Algar. (2012). Methods for the detection of

histone acetylation in blood. Epigenetics.7:8, 1-8.

Nicholas C. Wong, David Ashley, Zac Chatterton, Mandy Parkinson-Bates, Hong Kiat Ng, Minhee S.

Halemba, Adam Kowalcyk, Justin Bedo, Qiao Wang, Katrina Bell, Elizabeth Algar, Jeff Craig and

Richard Saffery. (2012) A distinct DNA methylation signature defines paediatric pre-B cell acute

lymphoblastic leukaemia. Epigenetics, Jun 1 Volume 7 (6) pp 535-541.

Elizabeth Algar, Andrea Muscat, Vinod Dagar, Christian Rickert, CW Chow, Jacqueline Biegel, Paul

Ekert, Ricky Johnstone and David Ashley. (2009). Imprinted CDKN1C is activated by histone

deacetylase inhibitors and restoration of SMARCB1 in rhabdoid tumor. PLoS ONE 4(2): e4482.

doi:10.1371/journal.pone.0004482.

Tomasz K. Wojdacz, Alexander Dobrovic and Elizabeth M. Algar. (2008) Rapid detection of

methylation change at H19 in human imprinting disorders using methylation sensitive high

resolution melting. Human Mutation Vol. 29, p1255-1260.

Meredith Wilson, Gregory Peters, Bruce Bennetts, George McGillivray, Zan He Wu, Christopher

Poon, Elizabeth Algar. (2008). The Clinical Phenotype of Mosaicism for Genome-wide Paternal

Uniparental Disomy: Two New Reports. American J. Med Genetics. Part A. Vol. 146A p137-

148.

Meyepa L, Globin chain separation for alpha/beta thal diagnosis on HPLC, poster

presentation, HSA New Zealand, 1997

Swain M, Reticulocyte performance on the Cell Dyn 3500, poster presentation, AIMS

Perth, 1997

Howells S, Hypercoaguable screen for DVT patients - when should they be performed,

poster presentation, AIMS Perth, 1997

Wheeler M, RCPA - QA and educational broadsheet on Protein C and Protein S, poster

presentation, HAS Sydney, 1998

Wheeler M, Evaluation of a portable monitor for INR determinations (OP and HIH

evaluation of the CoaguCheck), poster presentation, ISTH Washington, 1999

Murphy B, Positive lupus anticoagulant tests and thrombotic risk (A comparison of

different methods in 500 requests - aptt, tti, rvv, Auto kct), poster presentation, ASBT

Melbourne, 1999

Snooks J, Current trends in usage of autologous blood (a comparison of today’s data c/w

that of 5 years ago), poster presentation, ASBT Melbourne, 1999

Wheeler M, New Technologies in the Coagulation Laboratory, Invited speaker, AIMS

Sydney, 2000

Wheeler M, Near Patient Testing for oral Anticoagulation Monitoring, Invited speaker,

AIMS

Sydney, 2000

Meyepa L, Detection of the PT20210A mutation using allele specific PCR, poster

presentation, HAS Perth, 2000

Swain M, An automated Ddimer assay, adapted for the IL futura (c/w dimertest latex and

nycocard), poster presentation, AIMS Sydney, 2000

Turner C, Life threatening haemolytic transfusion reaction in haemoglobinopathy patients,

poster presentation, HAS Perth, 2000

Erica Malan Prevalence of positive thrombophilic markers in DVT patients, poster

presentation, HSA Perth, 2000

Allwright J, Evaluation of transfusion protocol for T activated neonates, poster

presentation, AABB

Washington, 2000

Butler J, Assessment of the PFA-100 in cardiopulmonary bypass surgery, poster

presentation, ISTH Paris, 2001

Butler J, Evaluation of the PFA-100 in a busy routine laboratory for diagnosis of platelet

dysfunction and its utility in the monitoring of DDAVP response before surgery, poster

Hae

mat

olo

gy

presentation, ISTH Paris, 2001

Wheeler M, Evaluation of near patient testing using portable INR monitors in an

anticoagulant clinic (CoaguChek and Protime), poster presentation, HSA Brisbane, 2001

Malan E, LMW Heparin monitoring during IVF pregnancy, poster presentation, HSA

Brisbane, 2001

McPhee G, Polyethylene glycol (PEG) enhanced adsorption to isolate alloantibodies with

free autoantibodies: a two year experience of a routine blood bank laboratory, poster

presentation, HSA Brisbane, 2001

Bennett V, A performance evaluation of the Abbott Cell Dyn 3700, poster presentation,

AIMS Melbourne, 2001

Jaskolowski S, Wheeler M, An evaluation of the Coulter LH750, invited speaker, Beckman

Coulter Victorian launch, Melbourne, 2002

Wheeler M, Jaskolowski S, An evaluation of the Coulter LH750, invited speaker, Beckman

Coulter NZ users group meeting, Auckland, 2002

Jaskolowski S, Choong S, Malan E, Wheeler M, Gan T, Opat S, Anticoagulant control in a

specialist haemostasis clinic with point of care testing - an 18 month review, HSANZ/ASBT

National meeting, Adelaide, 2002

Weinhandl JA, Allwright JE, Gan TE, Using pretransfusion samples collected more than 72

hours before transfusion. Is it safe?, HSANZ/ASBT National Meeting, Adelaide, 2002

Butler J, HITTS, Lepuridin and bypass surgery - a successful outcome, invited speaker,

National HITTS Meeting, Sydney, 2003

Butler J, Coagulation and the bleeding patient, Invited speaker, HDG/VIDG Meeting, 2003

Allwright J, Prophylactic anti D, Invited speaker, VIDG/HDG Meeting, 2003

Wheeler M, Malan E, Gan TE, et al, A prospective multicentre study assessing the random

error rates of routine coagulation tests, poster presentation, ISTH Birmingham, 2003

Tran H, Wheeler M, Gan TE, A pilot study - efficacy of low dose warfarin with PF12

monitoring in high risk VTE patients, poster presentation, ISTH Birmingham, 2003

Favaloro E, Wheeler M, et al, Laboratory diagnosis of congenital thrombophilia: current and

past practice in Australia, poster presentation, ISTH, Birmingham, 2003

Bennett V, Wheeler M, Opat S, Neonatal morphology - a retrospective review at Monash

Medical Centre, poster presentation, AIMS NSM, Gold Coast, 2003

Rushford K, Meyepa L, Butler J, Wheeler M, Gan T, Opat S, Testing for Factor V Leiden by a

functional clotting method and a genetic test : experience of a hospital referral laboratory,

poster presentation, AIMS NSM, Gold Coast, 2003

Rushford K, Meyepa L, Wheeler M, Gan T, Opat S, Hyperhomocysteinaemia and the MTHFR

genetic abnormality, poster presentation, AIMS NSM, Gold Coast, 2003

Kenealy M, Butler J, Opat S, Control of cerebral haemorrhage with recombinant factor VIIa

in a patient overanticoagulated with LMWH, poster presentation, HSANZ, Christchurch,

2003

Gan TE, Wheeler M, Malan E, Goergen S, et al, A prospective study assessing the clinical

utility of Ddimer levels and a clinical risk assessment model for the exclusion of pulmonary

embolism, prize winning poster presentation, HSANZ, Christchurch, 2003

Meyepa L, Gan TE, Bowden D, Opat S, Investigation of rare haemoglobin variants, poster

presentation, HSANZ, Christchurch, 2003

Favaloro E, Wheeler M, et al, Laboratory diagnosis of congenital thrombophilia: current and

past practice in Australia, poster presentation, HSANZ, Christchurch, 2003

Butler J, Malan E, Gan TE, HITTS, Lepirudin, Bypass surgery – a successful outcome, Invited

speaker, National HITTS school, Sydney, 2003

Grey D, Allwright J, et al, Haemolytic disease of the newborn caused by a new kell antigen,

prize winning poster presentation, BBTS, Manchester, 2003

Haywood J, A new Kell blood group, invited speaker, AIMS Vic branch weekend conference,

Castelmaine, 2004

Goergen S, Gan TE, Wheeler M, et al, Reducing the use of diagnostic imaging in patients

with suspected PE: validation of a risk strategy, publication submitted to Annals of

Emergency Medicine, 2004

Gan T.E, Butler.J, Malan.E, .Lepirudin in Coronary Artery Bypass Surgery – the local

experience, poster Fibrinolysis conference, Melbourne 2004

Manikappa.S. Benfield.K., Gan TE, Butler.J., Malan. E, Heparin-induced thrombocytopenia

and use of r-hirudin during CPB, Publication submitted to Anaesthesia and Intensive Care.

2004

Peverill.R. Gan.TE, Malan.E., Teede, et al, .Effect of hormone therapy on VWF in post-

menopausal women. –submitted as letter to Editor to Journal of Thrombosis and

Haemostasis. 2004

Peverill.R., Smolich.J., Malan.E. – Comparison of effects of Pravastatin and hormone therapy

on S.P-selectin and platelet P-selectin expression in post-menopausal hypercholesterolemic

women submitted for publication to Cardiology. 2004

Teede.H., Dalais.F., Kotopoulos .D., McGrath.B., Malan.E.,Gan.T.E.,Peverill.R Dietary soy-

containing phytoestrogens does not activate the haemostatic system in post-menopausal

women –submitted for publication to Journal of Clinical Endrocrinol. Metab. 2004

Favaloro E, Wheeler M, et al, Multi laboratory testing of thrombophilia: current and past

practice in Australasia as assessed through the RCPA QA program for haematology, Semin

Th Haemost, 31(1) Feb 2005

Favaloro E, Wheeler M, et al An international survey of current practice in the laboratory

assessment of anticoagulation therapy with heparin, Pathology 37(3) June 2005

Wheeler M, Automation in a large laboratory, Invited speaker, Tasmanian Annual Scientific

meeting, Bridport, 2005

Wheeler M, Point of care testing, Invited speaker, Tasmanian Annual Scientific meeting,

Bridport, 2005

McPhee G, Allwright J, Wheeler M, Screening for Feto-maternal Haemorrhage using Acid

Elution Techniques, Poster presentation HSANZ /ASBT conference, Sydney, 2005

Viedra K, Zhong L, Wheeler M, Gan E, et al, Evaluation of Transferrin Receptor / Ferritin

Ratio in the Diagnosis of Iron Deficiency in Patients with other Medical Conditions – A Pilot

Study, Poster presentation HSANZ / ASBT conference, Sydney, 2005

Wheeler M, Butler J, Malan E, Gan T, An evaluation of the ACL TOP Coagulation

Autoanalyser, Poster presentation ISTH conference, Sydney, 2005

Malan E, Butler J, Gan T, The development of a protocol for Lepirudin Therapy Monitoring,

Poster presentation ISTH conference, Sydney, 2005

Butler J, Malan E, Gan T, Evaluation of diamed HPIA.... HITTS, Poster presentation ISTH

conference, Sydney, 2005

Favaloro E, Wheeler M, et al, How useful is the monitoring of (Low Molecular Weight)

Heparin Therapy by Anti-Xa Assay? A Laboratory Perspective, Lab Haem, 2005, 11:157-162

Meyepa L, Bowden D, Wheeler M, Gan TE. Raised HbF investigation in a haemoglobinopathy

screening program. Poster presentation, HSANZ National Scientific Meeting, Hobart, 2006.

Baker S, Wheeler M, Gan TE. Ultracentrifugation is acceptable for rapid routine coagulation

testing. Poster presentation, HSANZ National Scientific Meeting, Hobart, 2006.

Baker S, Wheeler M, Lewis A, Gan TE. The haematocrit test for neonatal patients – a

comparison of methods. Poster presentation, HSANZ National Scientific Meeting, Hobart,

2006.

Wheeler M. Automated coagulation analysers – initial evaluation and ongoing operation.

Invited speaker, AIMS National Scientific Meeting, Hobart, 2006.

Wheeler M. Point of care monitors and warfarin therapy control. Invited speaker, AIMS

National Scientific Meeting, Hobart, 2006.

Allwright J, Gen TE. Post transfusion hyperhaemolysis syndrome in sickle cell disease. Poster

presentation, ASBT National Scientific Meeting, Hobart, 2006.

Bennett V, Wheeler M, Lewis A, Gan TE. The full blood count and morphology results in

neonatal bacteremic septicaemia – a 12 month retrospective study. Poster presentation,

AIMS National Scientific Meeting, Hobart, 2006.

Peverill R, Malan E, et al. Comparison of effect of prarastatin and hormone therapy on Sol P-

Selectin and platelet P-Selectin expression. Maturitas, 2006, 53(2), 158-165

Clifford J, Meyepa L, Opat S, et al. Haemoglobin Rothschild presenting with low peripheral

oxygen saturation by pulse oximetry: A case report. Poster presentation, HSANZ National

Scientific meeting, Gold Coast, 2007

Trimnell T, Allwright J, Gan TE, et al. The clinical significance of Anti-M in pregnancy. Poster

presentation, HSANZ National Scientific meeting, Gold Coast, 2007

Butler J, Wheeler M, Malan E, Gan TE. A potential source of erroneous results on

coagulation analysers – an observational study. Poster presentation, ISTH international

scientific meeting, Geneva, 2007

Peverill R, Malan E, et al. Relationship of waist hip circumference with coagulation and

fibrinolysis in postmenopausal women, Clin Sci, 2007, 113, 383-390

Malan E et al, Evaluation of an ADAMTS13 Activity ELISA assay for routine use, Poster

presentation, ANZSBT National Scientific meeting, Perth, 2008

Malan E et al, Current status of INR point-of-care testing, , Invited speaker, ASTH national

workshop, Perth, 2008

Butler J, TTP, vWF and ADAMTS13, Invited speaker, AIMS National Scientific meeting,

Melbourne, 2008

Meyepa L, Haemoglobinopathy case studies, Invited speaker, AIMS National Scientific

meeting, Melbourne, 2008

Wheeler M, Error rates on Coagulation analysers, Invited speaker, Beckman Coulter User

group, Melbourne, 2008

Butler J, ACL curve analysis, Invited speaker, Beckman Coulter User group, Melbourne, 2008

Fitzmaurice A, Malan E, Butler J, Wheeler M, Tran H, Laboratory monitoring of oral

anticoagulant patients with lupus anticoagulant, Poster presentation HSANZ, Adelaide, 2009

Wheeler M, Qayum S, Jaskolowski S, An evaluation of the DxH800 automated cell counter,

Poster presentation AIMS national scientific meeting Adelaide, 2009,

Wheeler M, Qayum S, Jaskolowski S, An evaluation of the DxH800 automated cell counter,

Poster presentation Beckman national user group meeting, 2009,

Jaskolowski S, Wheeler M, Qayum S, An evaluation of the DxH800 automated cell counter,

Oral presentation Beckman national user group meeting, 2009,

Malan E, Factor VIII assay dilemas, Oral presentation Beckman national user group

meeting2009,

Butler J, Malan E, Clifford J, Wheeler M, Gan E, Evaluation of an ADAMTS13 activity ELISA

assay, Poster presentation ISTH, Boston, 2009

Hoskin E, Meyepa L, Wheeler M, Guirguis A, An evaluation of the Sebia Minicap capillary

electrophoresis analyser, Poster presentation AIMS national scientific meeting Adelaide,

2009,

Putrino A, Allwright J, Wheeler M, Comparison of antenatal antibody titres by automated

analyser and manual technique, Poster presentation, HSANZ, Adelaide, 2009,

Guirguis A, Malan E, Butler J, Wheeler M, LA testing sensitivity specificity, Poster

presentation, HSANZ, Adelaide 2009

Kaplan Z, Butler J Malan E, LA testing is uninterpretable in patients receiving Rivaroxaban

therapy for VTE, Eur Haem Assoc international scientific meeting, Barcelona2009

Merriman E, Kaplan Z, Butler J, Malan E, Gan E, Tran H ‘Rivaroxaban and false positive lupus

anticoagulant testing, Thromb Haemost, 2011, 105:2, 385-386

Wheeler M et al, Evaluation of a new automated immunological white cell differential,

Poster presentation, AIMS, Gold Coast2011,

Rushford K et al, Serological results in patients with autoantibodies – A single institution

retrospective audit, Poster presentation, ANZSBT, Sydney, 2011

Rushford K et al, Issues in the serial titration of clinically significant antibodies in an

antenatal patient, Poster presentation, ANZSBT, Sydney2011

Malan E, Evaluation of the HemosIL HIT test c/w established methods in the diagnosis of

HITTS, Poster presentation, HSA, Sydney2011

Rushford K, A single institution audit of transfusion practice and wastage of paediatric

packs of red cells, Oral presentation, NICE, Albury2011,

Hosken R, A national audit of titration of antenatal antibodies, Oral presentation, NICE,

Sydney, 2011

Wheeler M, Evaluation of a new automated immunological white cell differential, Poster

presentation, BCUG, Melbourne2011,

Rushford K, Rh(D) Immunoglobulin Therapy in the Treatment of Immune

Thrombocytopenic Purpura. Oral Presentation, NICE, Albury 2012,

Rushford K et al, Case Report of a Haemolytic Transfusion Reaction Due to anti-Colton(b),

Poster Presentation, HAA, Melbourne. 2012,

Rushford K, Hoskin E, et al, Frequency of Anti-Mia Antibodies in the Patient Population of a

Tertiary Hospital, Poster Presentation, HAA, Melbourne. 2012,

Rushford K, et al, Anaemia in Surgical Patients Attending a Preoperative Anaesthetic

Assessment Clinic, , Oral Presentation, HAA, Melbourne. 2012

Rushford K, et al, Albumin Traceability - Lesson Learnt from the Albuminex Recall, 2012,

Oral Presentation, HAA, Melbourne. 2012

Wheeler M, Meyepa L, MCV and MCH cutoffs for Haemoglobinopathy screenng, Poster

Presentation, HAA, Melbourne 2012,

Butler J, Malan E, et al. Establishing an Anti Xa assay to monitor the activity of Fondaparinux

in patients with Renal Failure. Poster presentation, HAA, Melbourne. 2012,

Butler J, Malan E, et al. Assessing the safety of a standard Enoxaparin dosing regimen in

obese patients with newly diagnosed Venous Thromboembolism, Poster presentation, HAA,

Melbourne. 2012

Butler J, Malan E, et al. The clinical outcomes of patients receiving Dabigitran and their

coagulation profile and renal function in a tertiary referral centre, Poster presentation, HAA,

Melbourne 2012

Biancofiore C, Malan E, Butler J. Evaluation of the Stago STic Expert HIT kit in the diagnosis

of HIT, Poster presentation, HAA, Melbourne. 2012

Butler J, Malan E, et al. A Correlation between the Hemoclot Dabigitran Assay and the

Activated thromboplastin time and Thrombin time in a tertiary referral centre., Poster

presentation, HAA, Melbourne, 2012.

Butler J, Malan E, et al, The effect of dabigatran on the activated partial thromboplastin

time and thrombin time as determined by the hemoclot thrombin inhibitor assay in patient

plasma samples. Poster presentation, ISTH Amsterdam 2013

Rushford K, Massive Transfusion Protocols, , Oral presentation, VIDG, Melbourne. 2013

Butler J, Malan E, et al, The effect of dabigitran on the activated partial thromboplastin

time and thrombin time as determined by the hemoclot thrombin inhibitor assay in patient

plasma samples. Thrombo Haemost 2013. (accepted for publication, in print for September

2013 issue)

Fedele P, Wheeler M, et al. ICT testing for malaria screening in refugee patients, poster

presentation, Pathology Update, 2013

Hapgood G, Butler J, Malan E, et al. The effect of dabigatran on the APTT and TT as

determined by the haemoclot TTI in patient plasma samples. Thrombosis and Haemaostasis,

2013, 110/2, 308-315.

Maclachlan K, Butler J, Malan E, et al, Appropriateness of ATS13 level requests to a

reference laboratory, ? need for pretesting advice, Poster presentation, HAA, 2013

Lee D, Butler J, Malan E, et al, Comparison of Prothrombin reagent sensitivities as an

alternative to the Chromogenic antiXa assay for Rivaroxaban monitoring, Poster

presentation, HAA, 2013

Malan E, et al, Dabigatran, APTT and TT, Poster presentation, ISTH Amsterdam, 2013

Handunetti S, Butler J, Malan E, et al, A case report of Dabigatran in emergency cardiac

surgery, Poster presentation, HAA, 2013

Malan E, Correlation of PT reagent sensitivities and Rivaroxaban, Poster presentation,

Werfen User group, 2013

Wallace J, Thrombotic Thrombocytopenic Purpura - Lab testing, Oral presentation AIMS Vic

HDG 2013,

Parker M, Bombay blood group - case study, Oral presentation AIMS Vic HDG, 2013,

Hoskin E, Malaria case study, Oral presentation AIMS VicHDG, 2013,

Butler J, Antithrombin deficiency - case study, Oral presentation AIMS Vic HDG, 2013,

Rushford J, Immune thrombocytopenia - a case study, Oral presentation, AIMS Vic HDG,

2013,

Fedele P, Wheeler M, et al. ICT testing alone is sufficient to identify asymptomatic refugees

at risk of severe malaria presenting to a single health service in Victoria, Pathology, 2014,

46(6), 551-554

Clifford J et al, The influence of NOAC on routine and specialised coagulation laboratory

testing, FAIMS Dissertation 2014

Parker M, Rushford K et al, The trials and tribulations of acquired Anti-JMH antibodies,

Poster Presentation, HAA, 2014

Lee N, Wheeler M, et al, Assessment of correlation and agreement between PT-derived

fibrinogen and Clauss method in a tertiary hospital, Poster presentation, HAA, 2014

Wheeler M, G6PD deficiency - A case study, Oral presentation, AIMS VicHDG, 2014

Cai H, Raised Haemoglobin, Oral presentation, AIMS VicHDG, 2014 Rushford K, PCH - A case study, Oral presentation, AIMS VicHDG, 2014 Butler J, Protein C deficient child - A case study, Oral presentation, AIMS VicHDG, 2014 Meyepa L, Hb A2 variants, Oral presentation, AIMS VicHDG, 2014 Hotchin S, Blood wastage audit, Oral presentation, AIMS VicHDG, 2014 Qayum S, Malan E, Butler J, The advantages of including Anti-Xa assays into routine lupus anticoagulant screening, Poster presentation HAA, Adelaide, 2015 Malan E, Butler J, et al, Homozygout Protein C deficiency – a case report, Poster presentation, HAA, Adelaide 2015 Cason, J, Malan E, Butler J, et al, Rivaroxaban in refractory HITT – A case report, poster presentation, HAA Adelaide, 2015 Wong J, Meyepa L, et al, Raised HbF as a screening test for silent B-globin gene mutations – a retrospective audit, poster presentation, HAA Adelaide, 2015

Sung P, Platelet dysfunction (BSS) – a case study, Oral presentation, AIMS VicHDG, 2015 Qayum S, Lupus anticoagulant testing, Oral presentation, AIMS VicHDG, 2015 Jaskolowski S, TAMS – A case study, Oral presentation, AIMS VicHDG, 2015 Davidson R, A difficult antibody (H1), Oral presentation, AIMS VicHDG, 2015

Mic

rob

iolo

gy Isolation of dermatophytes (and other fungi) from human nail and skin dust

produced by podiatric medical treatments in Australia. Hainsworth S, Hamblin JF, Vanniasinkam T.

J Am Podiatr Med Assoc. 2015 Mar; 105(2):111-20. doi: 10.7547/0003-0538-105.2.111. PMID:

25815649

Rapid Time to Results and High Sensitivity of the CarbaNP Test on Early Cultures.

Lee LY, Korman TM, Graham M. J Clin Microbiol. 2014 Nov;52(11):4023-6. doi:

10.1128/JCM.01682-14. Epub 2014 Aug 20. PMID: 25143572 [PubMed - in process]

Human wound infection with Mannheimia glucosida following lamb bite.

Lau JS, Omeleki L, Turni C, Barber SR, Browning GF, Francis MJ, Graham M, Korman TM. J Clin

Microbiol. 2015 Jul 22. pii: JCM.01249-15. [Epub ahead of print] PMID: 26202121

Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1

gene in Australia. Tai A, Stuart RL, Sidjabat H, Lemoh C, Rogers BA, Graham M, Paterson DL,

Korman TM. Med J Aust 2015 Mar 16;202(5):270-1.

Acanthamoeba encephalitis: isolation of genotype 1 in mycobacterial liquid culture media. Azzam

R, Francis MJ, Fernandez C, Badenoch P, Adamson P, Dendle C, Woolley IJ, Robson J, Korman TM,

Graham M J Clin Microbiol. 2014 Dec 10. pii: JCM.02887-14. [Epub ahead of print] PMID:

25502534 [PubMed - as supplied by publisher]

Evaluation of the Sofia Influenza A & B, Respiratory Syncytial Virus and Legionella Fluorescent Immunoassays on the Sofia Analyser Megan Wieringa- Monash Medical Centre, VIC Primary Diagnosis of Disseminated Coccidioidomycosis in a Skin Nodule from a Returned Traveller M.J.Francis*, K.Lim, M.Graham, M.Khuu, J.F.Hamblin and T.M.Korman 19th ISHAM Congress, 4-8 May 2015 Melbourne Convention and Exhibition Centre